These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 4051835

  • 1. Neurochemical changes in white matter. Aged human brain and Alzheimer's disease.
    Malone MJ, Szoke MC.
    Arch Neurol; 1985 Nov; 42(11):1063-6. PubMed ID: 4051835
    [Abstract] [Full Text] [Related]

  • 2. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP, Yao J, Yin F, Fonteh AN, Harrington MG, Christensen TA, Trushina E, Brinton RD.
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [Abstract] [Full Text] [Related]

  • 3. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease.
    Roher AE, Weiss N, Kokjohn TA, Kuo YM, Kalback W, Anthony J, Watson D, Luehrs DC, Sue L, Walker D, Emmerling M, Goux W, Beach T.
    Biochemistry; 2002 Sep 17; 41(37):11080-90. PubMed ID: 12220172
    [Abstract] [Full Text] [Related]

  • 4. Decreased myelin lipids in Alzheimer's disease and vascular dementia.
    Wallin A, Gottfries CG, Karlsson I, Svennerholm L.
    Acta Neurol Scand; 1989 Oct 17; 80(4):319-23. PubMed ID: 2816288
    [Abstract] [Full Text] [Related]

  • 5. [Studies in the white matter of Alzheimer's disease--morphological, lipid-chemical investigation].
    Yokoi S, Nakano T, Suzuki K.
    No To Shinkei; 1982 Dec 17; 34(12):1197-205. PubMed ID: 7159549
    [No Abstract] [Full Text] [Related]

  • 6. White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments.
    Englund E, Brun A.
    Histopathology; 1990 May 17; 16(5):433-9. PubMed ID: 2361659
    [Abstract] [Full Text] [Related]

  • 7. Decrease in nerve fibres in cerebral white matter in progressive subcortical vascular encephalopathy of Binswanger type. An electron microscopic study.
    Yamanouchi H, Sugiura S, Tomonaga M.
    J Neurol; 1989 Oct 17; 236(7):382-7. PubMed ID: 2809638
    [Abstract] [Full Text] [Related]

  • 8. Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.
    Nguyen TV, Hayes M, Zbesko JC, Frye JB, Congrove NR, Belichenko NP, McKay BS, Longo FM, Doyle KP.
    Acta Neuropathol Commun; 2018 Sep 24; 6(1):100. PubMed ID: 30249297
    [Abstract] [Full Text] [Related]

  • 9. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis.
    Han X, M Holtzman D, McKeel DW, Kelley J, Morris JC.
    J Neurochem; 2002 Aug 24; 82(4):809-18. PubMed ID: 12358786
    [Abstract] [Full Text] [Related]

  • 10. Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects.
    Wood PL, Barnette BL, Kaye JA, Quinn JF, Woltjer RL.
    Acta Neuropsychiatr; 2015 Oct 24; 27(5):270-8. PubMed ID: 25858158
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
    Katsel P, Li C, Haroutunian V.
    Neurochem Res; 2007 Oct 24; 32(4-5):845-56. PubMed ID: 17342407
    [Abstract] [Full Text] [Related]

  • 14. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.
    Brun A, Englund E.
    Ann Neurol; 1986 Mar 24; 19(3):253-62. PubMed ID: 3963770
    [Abstract] [Full Text] [Related]

  • 15. The morphologic and neurochemical basis of dementia: aging, hierarchical patterns of lesion distribution and vulnerable neuronal phenotype.
    Hof PR, Giannakopoulos P, Vickers JC, Bouras C, Morrison JH.
    Rev Neurosci; 1995 Mar 24; 6(2):97-124. PubMed ID: 8564027
    [Abstract] [Full Text] [Related]

  • 16. Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia.
    Erkinjuntti T, Benavente O, Eliasziw M, Munoz DG, Sulkava R, Haltia M, Hachinski V.
    Arch Neurol; 1996 Apr 24; 53(4):325-32. PubMed ID: 8929154
    [Abstract] [Full Text] [Related]

  • 17. Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease--a neuropathological study.
    Sjöbeck M, Haglund M, Englund E.
    Int J Geriatr Psychiatry; 2005 Oct 24; 20(10):919-26. PubMed ID: 16163742
    [Abstract] [Full Text] [Related]

  • 18. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease.
    Perry EK, McKeith I, Thompson P, Marshall E, Kerwin J, Jabeen S, Edwardson JA, Ince P, Blessed G, Irving D.
    Ann N Y Acad Sci; 1991 Oct 24; 640():197-202. PubMed ID: 1723256
    [Abstract] [Full Text] [Related]

  • 19. Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects.
    Skinner ER, Watt C, Besson JA, Best PV.
    Brain; 1993 Jun 24; 116 ( Pt 3)():717-25. PubMed ID: 8513399
    [Abstract] [Full Text] [Related]

  • 20. Serum amyloid A in Alzheimer's disease brain is predominantly localized to myelin sheaths and axonal membrane.
    Chung TF, Sipe JD, McKee A, Fine RE, Schreiber BM, Liang JS, Johnson RJ.
    Amyloid; 2000 Jun 24; 7(2):105-10. PubMed ID: 10842712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.